Quantum Biopharma's shares are also listed on the Canadian Stock Exchange and the Frankfurt Stock Exchange. The company offers biotech solutions for the treatment of various diseases, including neurodegenerative diseases, metabolic syndromes and alcoholism.
The company is currently set to receive #cryptocurrency funding as well as other types of cryptocurrency transactions, Quantum said in a statement Quantum said in a statement, but did not disclose which tokens would be added to the company's cryptocurrency portfolio.
More and more non-cryptocurrency companies are turning to cryptocurrencies to diversify their assets and hedge against inflation.
the latest U. S. Consumer Price Index (CPI) data showed that inflation in November 2024 #rose 2.7% year-on-year, up from 2.6% in October and in line with market expectations. On a monthly basis, the consumer price index rose 0.3% in November, the largest increase in seven months.
In November, wellness and herbal e-commerce company Ziva Technologies invested up to US$1 million in #BTC because of its potential as an inflation-resistant store of value. The plan was approved.
The day before, on Nov. 25, video hosting service Rumble revealed plans to include #bitcoin on its balance sheet. The board of directors approved the allocation of up to $20 million of the company's excess cash reserves in BTC.
Hoth Therapeutics, another biopharmaceutical company, added $1 million in bitcoins to its coffers on Nov. 20.
MicroStrategy has been following this strategy since 2020, becoming the largest corporate bitcoin holder with 439,000 BTC as of December 2024.
corporate giants such as Microsoft and Amazon are using the potential against inflation as a defense. In December, the Washington, D. C. -based National Center for Public Policy Research urged Amazon and Microsoft shareholders to add bitcoin to their government bonds under the guise of a potential hedge against inflation.
Microsoft shareholders voted against the reallocation at its annual general meeting on Dec. 10.
Read us at: Compass Investments